👋 Attending #NGIO Boston? If you're interested in learning more about how Veracyte's Biopharma Services can help guide your drug development programs book a meeting with our team, and meet Giovanna Loro, Business Development, Veracyte and Aurélie Auguste, Director Translational Data Analysis, Pharma Business Unit, Veracyte in Boston, following this link: https://lnkd.in/ehryjtej Our team looks forward to meeting you. #NGIO #oncology #drugdiscovery #drugdevelopment
Veracyte Biopharma Services
Fabrication de produits pharmaceutiques
Gain actionable insights to confidently advance every step of your oncology drug development programs.
À propos
Veracyte is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. We provide novel insights, expertise and capabilities that empower our biopharmaceutical partners to confidently advance every step of their oncology drug development programs.
- Site web
-
https://io.veracyte.com/
Lien externe pour Veracyte Biopharma Services
- Secteur
- Fabrication de produits pharmaceutiques
- Taille de l’entreprise
- 51-200 employés
- Siège social
- Marseille
- Type
- Société cotée en bourse
- Fondée en
- 2015
- Domaines
- precision medicine, Biopharma, biomarker signatures et Cancer care
Lieux
-
Principal
163 Avenue de Luminy
13009 Marseille, FR
Employés chez Veracyte Biopharma Services
Nouvelles
-
Mark your calendars: Veracyte is hosting a talk at #NGIO Boston, "Enhanced Multiplex IHC Technology for Precision Oncology." Giovanna Loro, Business Development, Veracyte and Aurélie Auguste, Director Translational Data Analysis, Pharma Business Unit, Veracyte look forward to meeting you there. #NGIO #oncology #drugdiscovery #drugdevelopment
-
Coming up at #NGIO Boston: Veracyte is excited to host "Enhanced Multiplex IHC Technology for Precision Oncology." Join us for a talk with Aurélie Auguste on how actionable insights can help advance your oncology drug development programs, including drug mechanism of action to biomarker analysis, clinical trial optimisation and companion diagnostics development. See you in Boston! #immunooncology #drugdiscovery #drugdevelopment
-
-
Looking for a reliable partner for your drug development programs in immuno-oncology? Next month, the Veracyte team, Giovanna Loro and Aurélie Auguste, will be at the Next Gen Immuno-Oncology Conference (#NGIO)- East Coast Edition in Boston. Book a meeting today to connect with our team in Boston - we look forward seeing you there! https://lnkd.in/ehryjtej #oncology #drugdiscovery #drugdevelopment
-
Veracyte Biopharma Services a republié ceci
Excited to share that my colleague, Alboukadel Kassambara just delivered an amazing presentation on work conducted at Veracyte about interpretable AI applied to the analysis of histopathological images. This innovative methodology, developed as part of our research program, was helpful to predict relapse in TNBC patients in collaboration with the MyProbe RHU consortium. #AI #HealthcareInnovation #TeamSuccess
-
-
Day 2 of the #ECDP2024 organized by the European Society of Digital and Integrative Pathology-ESDIP. Be sure to attend our lecture during the Machine learning and IA algorithm development I session, in the Alpha room today, June 6, 2:20 pm CEST with Alboukadel Kassambara. And visit our poster at 5:30 pm CEST, Exhibition Hall presented by Aurélie Collignon. #computationalPathology #oncology #drugdevelopment
-
-
Attending #ECDP2024, organized by the European Society of Digital and Integrative Pathology-ESDIP? Don't miss our poster presentation tomorrow, June 6th, at 5:30 pm CEST in the Exhibition Hall! Discover how our innovative approaches are transforming computational pathology and advancing oncology research. See you there! #computationalPathology # #oncology #drugdevelopment
-
-
Exciting news! We are excited to announce our upcoming presentation at #ECDP2024 organised by the European Society of Digital and Integrative Pathology- ESDIP! Join us on June 6th at 2:20 pm CEST for an insightful session presented by Alboukadel Kassambara, PhD, Cancer Biology & Bioinformatics, Associate director Bioinformatics & Biostatistics. This presentation will explore the latest advances in computational pathology, focusing on how our innovative deep learning model improves the accuracy of Immunoscore predictions in triple-negative breast cancer (TNBC). Don't miss this opportunity to explore the intersection of cutting-edge technology and oncology! Looking forward to seeing you! #computationalpathology #oncology #drugdevelopment #DeepLearning #TNBC #ClinicalOutcomes
-
-
Are you attending #ECDP2024, organized by the European Society of Digital and Integrative Pathology - ESDIP? If so, meet with the Veracyte R&D team! We look forward to discussing the power of digital pathology to revolutionize oncology and improve patient outcomes. See you there ! #computationalPathology #oncology #drugdevelopment
-
-
Looking for a reliable partner for your drug development programs in oncology? Meet our team Naouel El Asri and Valerie Balme Sinibaldi at booth 35131 at #ASCO24.
Join us at ASCO 2024 to explore Veracyte’s innovative approach to minimal residual disease (MRD) detection. Our team is at booth 35131 and ready to discuss how our advanced whole-genome sequencing and AI capabilities are transforming cancer care in collaboration with our biopharma partners. #ASCO24 #AIinHealthcare #MRD
-